AstraZeneca To Buy Blood Cancer Co. TeneoTwo For $1.3B
AstraZeneca said on Tuesday that it will acquire biotech company TeneoTwo Inc. for up to $1.27 billion to allow it to help develop new medicine to fight blood cancer....To view the full article, register now.
Already a subscriber? Click here to view full article